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The Runx3 transcription factor regulates cell fate decisions during embryonic
development and in adults. It was previously reported that Runx3 is strongly
expressed in embryonic and adult gastrointestinal tract (GIT) epithelium (Ep) and
that its loss causes gastric cancer. More than 280 publications have based their
research on these ﬁndings and concluded that Runx3 is indeed a tumour
suppressor (TS). In stark contrast, using various measures, we found that Runx3
expression is undetectable in GIT Ep. Employing a variety of biochemical and
genetic techniques, including analysis of Runx3-GFP and R26LacZ/Runx3
Cre
or R26tdTomato/Runx3
Cre reporter strains, we readily detected Runx3 in GIT-
embedded leukocytes, dorsal root ganglia, skeletal elements and hair follicles.
However, none of these approaches revealed detectable Runx3 levels in GIT Ep.
Moreover, our analysis of the original Runx3
LacZ/LacZ mice used in the previously
reported study failed to reproduce the GIT expression of Runx3. The lack of
evidence for Runx3 expression in normal GIT Ep creates a serious challenge to
the published data and undermines the notion that Runx3 is a TS involved in
cancer pathogenesis.
INTRODUCTION
Runx3isoneofthethreemammalian Runtdomaintranscription
factors (TFs; Runx1, Runx2 and Runx3) comprising the highly
conserved RUNX gene family. Runx TFs are key gene expression
regulators of cell proliferation and lineage commitment during
embryonic development and in adults. Runx3 was originally
clonedbasedonitssimilaritytoRunx1(Levanonetal,1994)and
subsequently localized on human and mouse chromosomes 1
and 4, respectively (Avraham et al, 1995; Levanon et al, 1994).
Tissue-speciﬁc Runx3 expression is transcriptionally regulated
bytwoalternativecontrolregions,designatedthedistal(P1)and
proximal (P2) promoters (Fig 1A; Bangsow et al, 2001; Levanon
& Groner, 2004).
We previously published a detailed survey of the spatio-
temporal expression of Runx3 during embryonic development
(Levanon et al, 2001). Runx3 expression was examined at
embryonic day (E) 10.5 and between E14.5 and E16.5, and
compared to the expression pattern of Runx1. Immunohisto-
chemistry (IHC) and knock-in (KI) b-galactosidase activity
(LacZ staining) were used in parallel throughout this analysis to
rigorously determine the expression patterns of the two TFs.
Runx3 and Runx1 were readily detected in different compart-
ments of the haematopoietic system and also in the dorsal root
ganglia (DRG), epidermal appendages and developing skeletal
elements (Levanon et al, 2001). However, regarding epithelia an
interesting distinction was noted in the expression pattern of
Runx1 and Runx3. While Runx1 was expressed in various
epithelia including mucosa of the oesophagus and stomach, the
salivary glands ducts and the olfactory and respiratory mucosa,
Runx3 expression was undetectable in these epithelia (Levanon
et al, 2001).
Subsequently, Li et al (Li et al, 2002) reported that Runx3 is
highly expressed in GIT epithelial cells of E14.5 embryo and
adult mice and that its loss causes gastric cancer. In their study,
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into the Runx3 locus, enabling Runx3 expression to be
monitored by visualizing LacZ staining. In describing their
study, Li et al state that ‘Strong b-gal activity was found in
gastrointestinalorgans,includingthestomachandthesmalland
large intestines, from 14.5dpc through to adulthood’. This
statement was based on the ﬁnding that the GIT of their
Runx3
LacZ/LacZ knockout (KO) embryos was darkly stained by
LacZ, in striking contrast to the wild-type (WT) GIT. Many
investigators considered Li’s data (Li et al, 2002) and conclusion
that loss of Runx3 was involved in genesis of cancer, convincing
enough to launch studies on the potential involvement of Runx3
inadditional types ofcarcinoma. Theses studiesinvolved a wide
spectrum of tumours including bladder, brain, breast, color-
ectal, liver, lung, pancreas and prostate (Table S1 of Supporting
information lists 286 publications addressing association of
Runx3 loss with various cancers). Of note, the majority of these
published papers report Runx3 promoter methylation taken as
an indication for loss of Runx3 expression.
Clearly, the data reported by Li et al (Li et al, 2002) did not
correspond with our previously described ﬁndings regarding
Runx3 expression in GIT epithelium (Ep). However, given the
stringency of combined IHC and LacZ analysis that we had
employed (Levanon et al, 2001), it was not clear how we could
have missed such strong expression in a major organ,
particularly since all other LacZ-expressing sites shown in Li
et al corresponded with those reported previously by our own
group(Levanon etal, 2002,2001).The useofLacZKI reporterto
monitor expression is usually a reliable and highly sensitive
technique for determining gene expression levels. Therefore, in
light of these contradictory results, we concluded that the issue
ofRunx3expressioninthenormalGITEpneededtoberevisited.
In an attempt to resolve the discrepancy between Li’s report
and our results, we suggested at the time (Levanon et al, 2003)
the possibility that the positive detection of Runx3 in GIT by Li
et al was due to an artefact caused by the structure of the
targeting constructs used for creating the Runx3
LacZ/þ mouse
strains(Levanonetal,2002,2001;Lietal,2002).Lietal(Lietal,
2002) used a KO mouse (hereafter referred to as Kyoto-
Runx3
Lacz/LacZ), in which the LacZ-neomycin (neo) cassette was
inserted in-frame into exon 4 of the Runx3 gene, creating a
Runx3-LacZ fusion protein (Fig 1A). In contrast, we (Levanon
et al, 2001) used Runx3 KO mice (hereafter referred to as
Rehovot-Runx3
Lacz/LacZ) in which Runx3 was disrupted by
inserting an IRES-LacZ-neo cassette into exon 2 (Levanon et al,
2002). In theRehovot-Runx3
Lacz/LacZ mice,expression ofLacZ is
enabledbythepresenceofanIRES segment,whichresultsinthe
production of free LacZ protein (Fig 1A). Accordingly, it seemed
possible that the genetic manipulations used for preparation of
either of these mouse strains might have caused a change in the
expression pattern. However, the differences between the
targeted alleles of these Runx3
Lacz/LacZ mouse strains, as shown
here, do not reconcile the discrepancies in the published
ﬁndings.
Responding to these issues, we re-examined Runx3 expres-
sion in normal GIT Ep usinga variety of biochemical andgenetic
techniques including IHC with eight different anti-Runx3
antibodies (Abs),
35S-RNAin situhybridization (RISH),TaqMan
reverse transcription quantitative real-time polymerase chain
reaction (RT-qPCR) of FACS sorted GIT epithelial cells, analysis
of Runx3-GFP KI mice, analysis of R26-LacZ/Runx3
Cre and R26-
tdTomato/Runx3
Cremiceandrigorousre-analysisoftheoriginal
Kyoto-Runx3
Lacz/LacZ mice used by Li et al (Li et al, 2002). This
exhaustive analysis revealed no expression of Runx3 in GIT Ep
and, therefore, poses a serious challenge to the published data
and to the conclusion that Runx3 is a tumour suppressor gene
(TSG) whose inactivation is involved in gastric or colorectal
cancer. Of note, the detailed analysis documented herewith
demonstrated that of the various anti-Runx3 Abs used for
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Figure 1. Detection of Runx3 in WT and in Rehovot-Runx3
Lacz/R mice.
A. Scheme depicting the Runx3 gene and the targeted alleles used to
generate the Kyoto- and Rehovot- Runx3
LacZ/LacZ mice. The two
promoters (P1 and P2) and the corresponding initiator ATGs are
indicated. In Kyoto-Runx3
LacZ/LacZ mice, the LacZ was inserted in frame
into exon 4 of the gene creating a Runx3-LacZ fusion protein (Li et al,
2002). In Rehovot- Runx3
LacZ/LacZ mice, the gene was disrupted by
inserting an IRES-LacZ into exon 2 (Levanon et al, 2002).
B,C. The pattern of Runx3 expression at E14.5 revealed by whole mount LacZ
staining of Rehovot-Runx3
LacZ/þ embryo (B) and by IHC of WT embryo
using a sagittal section reacted with Poly-G Ab (C). Runx3 is strongly
expressed in whiskers (W), cartilage (C), thymus (T), DRG (D) and
haematopoietic cells in the liver (L), but not in the GIT (G).
D,E. Isolated LacZ-stained GIT of E14.5 Runx3
LacZ/þ embryo (D) and a
transverse section of the intestine of a WT embryo (E) immunostained
with poly-G Abs showing lack of detectable Runx3 in the epithelium (Ep).
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designated R3-1E10 (Ito et al, 2009) is an invalid reagent and
could not be construed as being speciﬁc for Runx3 protein.
Given the lack of Runx3 expression in a wide repertoire of other
epithelia, the data also calls into question the potential function
of Runx3 as TSG in other carcinomas. It is commonly accepted
that if a gene is never expressed in a cell type that gives rise to a
particular tumour, loss of its expression in that tissue cannot be
invoked to mechanistically explain the pathogenesis of such
tumours in that tissue.
RESULTS AND DISCUSSION
Analysis of tissue-specific expression of Runx3 by IHC and
LacZ staining
We ﬁrst repeated the detailed analysis of Runx3 expression
at E14.5 using combined whole mount LacZ staining (Rehovot-
Runx3
Lacz/þ) and IHC of sagittal sections with our original
(Levanon et al, 2001) anti-Runx3 polyclonal Ab, Poly-G
(Fig 1B–E). While these experiments yielded consistent results
that corresponded with the known phenotypic features of
Runx3
 /  mice (Levanon & Groner, 2009), they failed to reveal
the pronounced Runx3 expression in GIT Ep reported by Li et al
(Li et al, 2002). Next, we assessed Runx3 expression in embryos
and adult mice by IHC using four additional anti-Runx3
monoclonal or polyclonal Abs that were raised against various
regions of the protein, either by us or by others (Fig 2A).
Polyclonal anti-Runx3-Poly-SA was raised against a region of
Runx3 similar to that of anti-Runx3 Poly-G. The other three Abs
designated Pep-J, GS and Mono-G were raised against peptides
spanning Runx3 regions previously deﬁned by Ito et al (Ito,
2008) as being ‘exposed in the GIT’ (Fig S1 A–C of Supporting
informationandSupportinginformationtext:Evaluationofanti-
Runx3 Abs reliability). Of note, the analyses using all ﬁve Abs
(Fig 2A) failed to detect Runx3 in the GIT Ep (Fig 2B–F) even
though they readily detected Runx3 in other cell types in the
same or adjacent tissues, such as GIT-embedded leukocytes (in
the adult GIT) and the DRG neurons of embryos (Fig 2B–F).
More recently, the group of Yoshiaki Ito (the corresponding
author of Li et al, 2002) raised several new monoclonal anti-
Runx3 Abs (Ito et al, 2009) one of which (designated R3-1E10)
was used in their reports. We have evaluated three of those anti-
Runx3 Abs: R3-8C9, R3-3F12 and R3-1E10. R3-8C9 and R3-3F12
reacted with Runx3 in DRG and leukocytes, whereas, R3-1E10
did not (Fig S1B and C of Supporting information and
Supporting information text: Evaluation of anti-Runx3 Abs
reliability). Using R3-1E10 Abs on sections of either DRG or GIT
tissues, we conﬁrmed the ﬁnding of Ito et al (Ito et al, 2009) that
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Figure 2. Five different anti-Runx3 Abs fail to detect Runx3 in GIT
epithelium (Ep).
A. Scheme showing Runx3 protein structure indicating the position of
peptides used for generation of the five anti-Runx3 Abs (see Materials and
Methods Section for details). Poly-G, Poly-SA-, Pep-J and GS are rabbit
polyclonal Abs. Mono-G is a monoclonal Ab.
B. Transverse sections of adult WT (left) and Runx3
 /  (right) small intestine
immunostained with the Poly-G Ab. Runx3 was detected in WT
GIT-embedded leukocytes (left) but not in Runx3
 /  cells. No Runx3 was
detected in WT GIT Ep.
C. Transverse sections of the small intestine of an adult CX3CR1
GFP/þ mouse
(Jung et al, 2000) double-stained with Poly-G and anti-GFP Abs. In adult
GIT, Runx3 is expressed in dendritic cells (DCs) and intraepithelial
leukocytes (IEL). CX3CR1
GFP marks the GIT DCs. Runx3 was detected in GIT
IEL (black nuclear staining, see arrows in the enlarged right panel). Double
stainedRunx3/GFPpositive(browncell membranestaining)depictsRunx3
expressing DCs. No Runx3 was detected in GIT Ep.
D. Three distinct anti-Runx3 Abs (From left to right: Poly-G, Poly-SA and
Pep-J) detected Runx3 in small intestine Peyer’s patch (PP) and leukocytes
of adult mice, but not in GIT Ep.
E. Adult WT small intestine immunostained with Mono-G anti-Runx3 Ab
(left panel) and with 40-6-diamidino-2-phenylindole (DAPI) which stains
the nuclei of both leukocytes and epithelial cells (middle panel) and a
merged image of the two frames (right panel) revealing Runx3 expression
in GIT-embeded IEL, but not in the Ep.
F. In E14.5 WT embryos Mono-G Abs detected Runx3 in DRG (left) but not in
GIT (right). More details are presented in Fig S1 of Supporting information
and in Supporting information text: evaluation of anti Runx3 Abs).
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it did not react with either GIT epithelial cells or with the GIT-
embedded leukocytes (Fig S1C of Supporting information). Of
note, the inability of R3-1E10 to detect Runx3 in DRG and/or in
leukocytes, the two major and undisputed sites of Runx3
expression, disqualiﬁes it as a valid anti-Runx3 Ab. Supporting
this conclusion are the ﬁndings that the Mono-G Ab, which was
raised against the same GIT Ep ‘exposed’ region (Fig S1A of
Supporting information), readily reacted with Runx3 in GIT-
embedded leukocytes and DRG (Fig S1B and C of Supporting
information). Hence, results attained using R3-1E10 Ab should
be interpreted cautiously, particularly when its reaction with
GIT Ep serves as the sole evidence for Runx3 expression in that
tissue (Ito et al, 2008).
Regarding detection of Runx3 by IHC, it is important to note
that of the eight anti-Runx3 Abs (including R3-8C9 and R3-F12)
that we have tested, not a single one produced a reliable Runx3
signal when reacted with GIT Ep (Fig 2 and Figs S1 and S2 of
Supporting information). However, all these Abs readily
reacted with Runx3 in DRG and leukocytes. Given that GIT
epithelial cells are notorious for their high degree of non-speciﬁc
Ab binding, these ﬁndings pose a serious challenge to
published data detecting Runx3 in GIT Ep solely by IHC. The
data below demonstrating by various measures that Runx3
expression in undetectable in GIT Ep strongly supports this
conclusion.
As noted above, since the publication of the Li et al (2002)
paper, a rich literature has been published on the potential
involvement of Runx3 in a variety of cancers (Table S1 of
Supporting information). While the majority of these published
papers report Runx3 promoter methylation in human cancers as
an indication for loss of Runx3 expression, few also analyse
Runx3expressionbyIHC.WethusevaluatedRUNX3expression
in normal human GIT Ep. Sections of cardio-pyloric stomach
were immunostained with two highly speciﬁc anti-RUNX3 Abs
as compared to pre-immune serum (Fig S2 of Supporting
information). RUNX3 protein was clearly detected in the tissue-
embedded leukocytes, but not in the Ep (Fig S2 of Supporting
information). Thus, similar to our ﬁndings in the mouse GIT,
RUNX3 is undetectable in human gastric Ep.
Runx1, a member of the same TF family as Runx3, is readily
detected in GIT epithelium by IHC, LacZ staining and
35S-RNA
in situ hybridization
In contrast to our inability to detect Runx3 expression in GIT Ep,
we previously detected the expression of the RUNX family
member Runx1 in GIT Ep (Levanon et al, 2001). This epithelial
expression was also re-examined here using both IHC with anti-
Runx1 Abs and LacZ staining of Runx1
LacZ/þ mice (North et al,
1999). As shown in Fig 3A and B, Runx1 was readily detected in
GIT Ep. Moreover, the intensity of immunostaining in GIT Ep
(Fig 3A) correlated well with that of the whole mount LacZ
staining (Fig 3B).
We used the expression of Runx1 as a control to evaluate GIT
expression of Runx3 by
35S-RISH. Both Runx3 and Runx1 are
expressed in DRG (Levanon et al, 2001), but in different classes
of neurons; Runx3 is expressed in TrkC neurons, whereas,
Runx1 is expressed in TrkA neurons (Chen et al, 2006; Kramer
et al, 2006; Levanon et al, 2002). Analysis of WT embryos using
35S-labelled probes revealed Runx3-
35S-RISH signals in DRG but
not in gastric Ep, whereas, Runx1 was detected in both organs
(Fig 3C). Runx1 signals were high in the fore-stomach and lower
in the glandular stomach region.
Collectively, these expression results of Runx3 and Runx1
demonstratedthatwhileRunx1wasclearlydetectableinGITEp,
Runx3 could not be detected. Accordingly, the conclusion that
Runx3 (both mRNA and protein) is absent in GIT Ep was
conﬁrmed by the results of three straightforward and sensitive
procedures: LacZ staining, IHC (with several Abs) and
35S-RISH,
which were used in parallel to assay the expression of Runx1
and Runx3.
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Figure 3. Expression of Runx1, a fellow family member of Runx3, is easily
detected in GIT epithelium (Ep).
A. Sections of E16.5 forestomach of WT and Runx1-P2
Neo/Neo embryos
immunostained with anti-Runx1 Ab show Runx1 expression in WT but not
in the negative control Runx1-P2
Neo/Neo forestomach (adapted from
Pozner et al, 2007).
B. Whole mount LacZ stained stomach of WT (left) and Runx1
LacZ/þ (right)
E14.5 embryos. LacZ staining was more prominent in the forestomach.
C.
35S-RNA in situ hybridization analysis of Runx1 and Runx3 expression in
embryonicDRGandstomach.DRGandstomachofE16.5 WTembryoswere
hybridized with a Runx3 probe (left panels) and a Runx1 probe (right
panels). Both probes detected expression in the DRG (Runx1 in TrkA
neurons and Runx3 in TrkC neurons), but only the Runx1 probe detected
expression in gastric Ep. F, forestomach, G, glandular stomach (adapted
from Brenner et al, 2004).
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GFP-positive GIT epithelial cells
One alternative to the use of a LacZ reporter is the widely used
green ﬂuorescent protein (GFP) reporter gene. Its high
expression level, when encoded as a non-fused protein, and
its inherent stability make it an invaluable tool for recording
spatialandtemporalpatternsofgeneexpressioninvivo.Inorder
to further evaluate the GIT epithelial expression of Runx3, we
generated KI mice in which the GFP variants AFP or
EGFP were placed downstream of the Runx3 P1 or P2
initiator ATG, respectively (Fig 4A). These Runx3
P1-AFP/þ and
Runx3
P2-EGFP/þ mice were mated to create compound hetero-
zygous (Runx3
P1-AFP/P2-EGFP) mice.
We found that the GFP expression pattern of E14.5
Runx3
P1-AFP/P2-EGFP mice recapitulated the pattern of Runx3
expression obtained using LacZ and/or IHC (Fig 1B and C
and Levanon et al, 2002, 2001), including expression in
the DRG, skeletal elements and epidermal appendages
(Fig 4B). To analyse GFP expression in GIT Ep in a more
stringent manner, we took advantage of the commercial
high avidity anti-GFP Ab to detect Runx3 by IHC. Immunos-
tained sections of the E14.5 embryos showed intense
signals in DRG and vertebrae, but none in the GIT Ep
(Fig 4C). We also used the anti-GFP Ab to immunostain GIT
of adult mice (Fig 4D). In this case as well, Runx3 expression
was detected in GIT-embedded leukocytes, but not in GIT Ep
within the same section (Fig 4D). These results, demonstrating
the lack of Runx3 expression in GIT Ep of Runx3-GFP mice,
correspond with the LacZ, IHC and
35S-RISH results shown
above.
We then assessed Runx3 expression in GIT epithelial
cells of adult Runx3
P1-AFP/P2-EGFP mice by ﬂow cytometric
analysis of GFP expressing cells. We utilized the expression
of Runx3 in GIT IEL (Fig 2B–E) as a control to
evaluate Runx3 expression in the epithelial cells. Single-
cell suspensions were prepared from the intestine of adult
Runx3
P1-AFP/P2-EGFP mice, and GFP expression was simulta-
neously monitored in EpCAM
þ epithelial cells and CD45
þ
IEL (Fig 4E and F). Even though the relative abundance
of IEL in GIT Ep cell-suspensions is low compared to
the epithelial cells, CD45
þ/GFP
þ double-positive cells
were readily detected (Fig 4E), whereas, there were no GFP
signals associated with the EpCAM
þ epithelial cell population
(Fig 4F). These results further demonstrate that Runx3
expression in the GIT Ep was undetectable even by the
highly sensitive ﬂuorescence activated cell sorter (FACS)
analysis.
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Figure 4. Analysis of Runx3 expression in Runx3
P1-AFP/P2-GFP compound
KI mice.
A. A scheme of the P1-AFP and P2-EGFP targeted alleles used to generate
the Runx3-GFP reporter mice.
B. Whole mount view of Runx3
P1-AFP/þ, Runx3
P1-AFP/P2-GFP and
Runx3
P2-GFP/þ (from left to right) E14.5 embryos.
C. Sagittal sections of DRG and GIT of E14.5 Runx3
P1-AFP/P2-GFP
embryos immunostained with anti-GFP Abs. GFP was detected in
DRG and vertebrae, but not in gastric and intestinal epithelium
(Ep).
D. Sections of adult Runx3
P1-AFP/P2-GFP GIT (small intestine, left; colon, right)
immunostained with anti-GFP Abs show GFP positive leukocytes in
Peyer’s patch (PP) and IEL and in leukocytes within the lamina propria,
while the adjacent Ep is unstained.
E,F. Flow cytometric analysis of GFP expression in single cell-suspensions of
GIT Ep of adult Runx3
P1-AFP/P2-GFP mice. Histograms demonstrating
EGFP/AFP expression in CD45
þ IEL (E) or EpCAM
þ epithelial cells (F) of
Runx3
P1-AFP/P2-GFP GIT (green) compared to WT (red). No GFP
positive GIT epithelial cells (F) were detected. Results from one of
four Runx3
P1-AFP/P2-GFP and WT control mice with the same
findings are shown. The relative high mean fluorescence intensity
of both Runx3
P1-AFP/P2-GFP and WT GIT epithelial cells was
due to the known autofluorescence of epithelial cells (DaCosta et al,
2005).
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Cre and R26-tdTomato/
Runx3
Cre mouse strains provide further evidence for lack of
Runx3 expression in GIT epithelium
To further explore Runx3 expression in WT mice, we used Cre
recombinase reporter strains harbouring either the LacZ or
tdTomato gene within the ROSA26 locus (R26; Soriano, 1999;
Srinivas et al, 2001 and Materials and Methods Section). These
strains display ampliﬁed expression of LacZ or tdTomato
following Cre-mediated excision of loxP-ﬂanked (Floxed)
transcriptional ‘stop’ sequences (Soriano, 1999; Srinivas et al,
2001). To faithfully replicate the native Runx3 expression
pattern,wegeneratedRunx3-Cre KImice(Runx3
Cre)harbouring
a GFP-Cre cassette in Runx3 exon 4 (Fig 5A). Of note, the
cassette was inserted in-frame into the unique SmaI site, which
was originally used to generate the Kyoto-Runx3
LacZ/
LacZ mice
(see Materials and Methods Section). Thus, the expression of
Cre in this Runx3
Cre mouse strain recapitulates the LacZ
expression mode of the Kyoto-Runx3
LacZ/
LacZ mice (Li et al,
2002). Upon crossing Runx3
Cre mice into R26-stop
Floxed-LacZ or
R26-stop
Floxed-tdTomato mice, the reporter (i.e. LacZ or
tdTomato) is switched on in all cells expressing Runx3 and
from then onconstitutively expressed within the R26 locus. This
occurrence generates a permanent genetic mark, which is
transmitted to all progeny cells allowing to trace not only
constant but also transient expression of Runx3 even in rare cell
populations.WhenE14.5R26-LacZ/Runx3
CreorR26-tdTomato/
Runx3
Cre embryos were analysed, we found no sign of Runx3
expression in GIT Ep (Fig 5B, C and F), in striking contrast to the
intense Runx3
Cre-mediated expression in all other Runx3-
expressing organs (Levanon et al, 2002, 2001; Li et al, 2002;
Fig 5B and F, also see Fig 1). The undetectable expression of
LacZ or tdTomato in normal GIT Ep precludes the possibility
that Runx3 is expressed in small progenitor compartments of
epithelial cells.
We then used the R26-LacZ/Runx3
Cre or R26-tdTomato/
Runx3
Cre mice to assess Runx3 expression in embryonic GIT Ep
by ﬂow cytometric analysis. For LacZ analysis, we employed
ﬂuorescein di-b-D-galactopyranoside (FDG), one of the
most sensitive ﬂuorogenic substrates available for detecting
b-galactosidase. As Runx3 was previously detected in the
thymus and liver of the developing embryo (Collins et al, 2009;
Levanon et al, 2001; Woolf et al, 2003; GenePaint.org
http://www.genepaint.org/Frameset.html, and Fig 1C and 5B),
we used the expression of Runx3 in thymocytes as a control to
evaluate its expression in the GIT. Single-cell suspensions were
prepared from the thymus and GIT of E16.5 WT and R26-LacZ/
Runx3
Cre embryos, and LacZ (FDG) was simultaneously
monitored in epithelial cells and thymocytes (Fig 5D and E).
While CD45
þ/FDG
þ double-positive cells were readily detected
in the thymocytes (Fig 5D), no FDG signals were associated with
the EpCAM
þ epithelial cell population (Fig 5E).
We next assessed Runx3 expression in GIT epithelial cells by
ﬂow cytometric analysis of tdTomato
R epithelial cells of
R26-tdTomato/Runx3
Cremice(Fig 5GandH).Takingadvantage
ofthe intensively ﬂuorescenttdTomato protein, we showthat as
with LacZ, E16.5 thymocytes co-expressed CD45 and tdTomato
whereas EpCAM
þ cells did not express tdTomato (Fig 5G). In
adults we utilized, as in Fig 4E and F, the expression of Runx3 in
GIT-embedded IEL as a control for Runx3 expression in the
epithelial cells. Single-cell suspensions were prepared from the
intestine of adult R26-tdTomato/Runx3
Cre mice, and tdTomato
was examined by FACS analysis. tdTomato was simultaneously
monitored in EpCAM
þ epithelial cells and CD45
þ IEL (Fig 5H).
Naturally, most of the cells in GIT Ep cell suspensions are
epithelial cells, while the GIT-embedded IEL constitute a minor
fraction (see Fig 2C). Moreover, Runx3 is expressed only in
certain subsets (CD8þ, DCs NK) of the CD45
þ cells as evidenced
by CD45
þ/tdTomato
þ double-positive cells (Fig 5H). Although
Runx3
þ CD45
þ subsets differ in their level of Runx3 expression,
thereporterproducesanequalsignalforallpopulations,reﬂecting
the constitutive activity of the R26 locus. In contrast to the CD45
þ
cells, no tdTomato signals were associated with the EpCAM
þ
epithelial cell population, evidenced by the lack of reporter signal
with R26-mediated intensity seen in CD45
þ cells (Fig 5H).
We next recorded the expression of Runx3 by RT-qPCR.
Employing ﬂow cytometric analysis, we isolated EpCAM
þCD45
 
epithelial cells from adult GIT and used splenic CD45
þNK cells
as a positive control. RT-qPCR was conducted using Runx3-
speciﬁc TaqMan primers. Strikingly, the expression of Runx3 in
the positive control CD45
þNK cells was 2257 fold higher relative
to the EpCAM
þ epithelial cells as calibrator (p¼0.001; Fig 5I).
Of note, the CD45
þNK cells signal appeared at cycle 26.2,
whereas, that of the EpCAM
þ epithelial cells arose at greater
than 35 cycles (at cycle 37), more than 5 cycles higher than any
other assay for an equivalent RNA input. By these standard
criteria, we interpret the recorded values to mean that there is
effectively no true target for Runx3 primers in WT GIT Ep.
Taken together, these results demonstrate that Runx3
expression was undetectable in embryonic and adult GIT Ep
even when TaqMan RT-qPCR or the highly sensitive combina-
tion of enhanced expression of R26-LacZ or R26-tdTomato and
FACS analysis was used. Importantly, the absence of FDG or
tdTomato positive EpCAM cells indicates that Runx3 was not
even transiently expressed at any time point during epithelial
lineage development.
Rigorous analysis of the original Kyoto-Runx3
LacZ/LacZ mice
failed to reproduce the reported LacZ staining in the GIT
In a further attempt to clarify the cause of the conﬂicting results
regarding Runx3 expression in GIT Ep, we recently obtained the
Kyoto-Runx3 KO mice used in the original study of Li et al (Li
et al, 2002). Male and female Kyoto-Runx3
LacZ/þ mice were
mated, and their progeny was analysed at E14.5. As
each pregnancy resulted in Runx3
þ/þ, Runx3
LacZ/þ and
Runx3
LacZ/LacZ embryos, the entire litter was ﬁrst stained for
LacZ and only subsequently genotyped. Based on the consensus
regarding Runx3 expression in DRG and skeletal elements of
E14.5 embryos (Inoue et al, 2002; Levanon et al, 2002, 2001; Li
et al, 2002; Yoshida et al, 2004), the level of LacZ staining in
these organs was used as a positive control reference.
Staining of either Kyoto-Runx3
LacZ/þ or Kyoto-Runx3
LacZ/LacZ
embryos revealed Runx3-LacZ expression in the DRG and
skeletal elements at intensities similar to those previously
observed in these mice (Li et al, 2002; Yoshida et al, 2004), yet
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Figure 5. LacZ or tdTomato expression in R26-LacZ/Runx3-
Cre or R26-tdTomato/Runx3
Cre mice and RT-qPCR analysis of Runx3 in GIT epithelial cells.
A. Scheme of the Runx3-GFP-Cre targeted allele used to create the Runx3
Cre mice. The GFP-Cre cassette was inserted in frame into the SmaI site used for the
generation of the Kyoto-Runx3
LacZ/LacZ mice (see Fig 1A).
B,C. LacZ expression in whole mount E14.5 R26-LacZ/Runx3
Cre embryo. The GIT, outlined in red (right panel), was excised, stretched and is shown magnified in
(C). W, whiskers; C, cartilage; T, thymus; L, liver; HF, hair follicles.
D,E. Flow cytometric analysis of Runx3 expression (FDG serves as a fluorescence substrate for b-gal) in thymocytes and GIT epithelial cells of E16.5 R26-LacZ/
Runx3
Cre embryos. (D) Histograms demonstrating detection of CD45
R/FDG
R double positive thymocytes (green) of R26-LacZ/Runx3
Cre embryo compared to
WT (red). (E) Absence of FDG
þ cells in GIT epithelial cells of either WT (red) or R26-LacZ/Runx3
Cre embryos (green). Results from one of four R26-LacZ/
Runx3
Cre and WT control embryos with same findings are shown.
F. tdTomato expression in whole mount E14.5 R26-tdTomato/Runx3
Cre (upper panel) or R26-tdTomato (lower panel) embryos. Red tdTomato fluorescence is
seenincartilageofskeletalelements,whiskers andhairfollicles.TheGITofbothR26-tdTomato/Runx3
CreandR26-tdTomato embryoswasexcised,stretched
and is shown magnified on the right.
G. Flow cytometric analysis of Runx3 expression (via tdTomato fluorescence) in thymocytes and GIT epithelial cells of E16.5 R26-tdTomato/Runx3
Cre embryos.
H. Flow cytometric analysis of tdTomato in single cell-suspensions of GIT epithelium (Ep) of adult R26-tdTomato/Runx3
Cre mice. Results from one of four adult
R26-tdTomato/Runx3
Cre mice with same findings are shown.
I. RT-qPCR analysis of Runx3 expression in splenic NK and GIT epithelial cells of adult WT mice. cDNAs of splenic CD45
þ NK cells and of sorted EpCAM
þCD45
 
GIT epithelial cells were analysed with Runx3, PBGD and HPRT TaqMan assays as detailed under Materials and Methods Section. Results were normalized to
endogenouscontrolgenesandcalculated relativetoacalibrator.Leftpanel.ExpressionofRunx3inCD45
þNKcellsis2257foldhigherrelativetotheEpCAM
þ
epithelial cells as calibrator (p¼0.001). The right panel depicts the expression of Runx3 in CD45
þNK cells and EpCAM
þCD45
  epithelial cells calculated
relative to the PBGD as calibrator (p¼0.001). Of note, signals produced by the EpCAM
þCD45
  GIT epithelial sample were consistently detected after more
than 35cycles, 5cycles higher than anyotherassay foran equivalentRNA input. By these standard criteria, we interpret therecorded values tomean thereis
effectively no true target for Runx3 in WT GIT Ep.
www.embomolmed.org EMBO Mol Med 3, 593–604  2011 EMBO Molecular Medicine 599no expression was detected in the GIT (Fig 6). In fact, staining of
the Kyoto-Runx3
LacZ/LacZ GIT was indistinguishable from that of
the WT (Runx3
þ/þ) littermate embryos. Moreover, increasing
the incubation time of isolated GIT with X-gal reagents to 2 days
still failed to yield detectable staining in the GIT (Fig 6). This
complete lack of LacZ staining in GIT of Kyoto-Runx3
LacZ/LacZ
embryos stands in direct contrast to the results reported by Li
et al that GIT of Kyoto-Runx3
LacZ/LacZ KO embryos was darkly
stained by LacZ and that this high LacZ expression persists in
adult mice (Li et al, 2002).
The consistent outcome of the immunostaining, in situ
hybridization, RT-qPCR experiment, analyses of Runx3-GFP
and R26-reporter (LacZ and tdTomato) mice and our failure to
reproduce the results of Li et al (Li et al, 2002) using the Kyoto-
Runx3
LacZ/LacZ mice demonstrate unequivocally that the
expression of Runx3 in GIT is below the detection limit of
these highly sensitive assays. Furthermore, the lack of Runx3-
Cremediatedreporterexpression showedthatRunx3isnoteven
transiently expressed at any stage of epithelial lineage
development. A TSG is commonly deﬁned as a gene normally
expressed in certain cells, whose loss or inactivation contributes
to tumour development in those cells. The evidence presented
here demonstrates that Runx3 does not satisfy the ﬁrst premise
of this deﬁnition and hence is highly unlikely to be a bona ﬁde
TSG in gastric or colorectal cancers as previously claimed.
It is worth noting, however, that the literature described
several examples of TSGs that are not expressed under normal
conditions but are activated as a consequence of oncogenic
stress (for example p16Ink4a; Bennecke et al, 2010). However,
this possibility was not considered by Li et al who attributed
their TS claim to loss of the pronounced Runx3 expression they
detect in normal GIT Ep. Equally signiﬁcant, this scenario was
not implicated by any, not even a single one, of the 286
published papers that based their research on the correctness of
Li et al and went on to postulate loss of Runx3 expression in
normal GIT Ep to explain the pathogenesis of various types of
cancer. On the contrary, in several epithelial cancers an
upregulation of RUNX3 expression was observed and in these
cases RUNX3 is considered an oncogene (Carvalho et al, 2005;
Lee et al, 2011; Nevadunsky et al, 2009; Salto-Tellez et al, 2006).
Potentially related are previous studies reporting that gene
alterations in stromal cells such as ﬁbroblasts (Bhowmick et al,
2004; Katajisto et al, 2008) and T cells (Kim et al, 2006) could
result in epithelial tumourigenesis. Indeed, Runx3 is
expressed in GIT leukocytes and its absence in Runx3
 / 
mice is associated with colonic inﬂammation and epithelial
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Figure 6. Absence of LacZ expression in GIT of the original Kyoto-Runx3
LacZ/LacZ KO mice. Upper panels depict whole mount LacZ staining of E14.5 WT,
Kyoto-Runx3
LacZ/þ and Kyoto-Runx3
LacZ/LacZ embryos. Shown are WT and Kyoto-Runx3
LacZ/þ stained for 48h and Kyoto-Runx3
LacZ/LacZ stained for 16h. Lower
panels depict the corresponding embryos GITs that were excised and stained for LacZ. There is complete absence of positive staining.
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et al, 2004) or others (Ito et al, 2008) observed an increased
incidence of GIT tumours or any other type of tumour. Thus, the
notion thatRunx3isabonaﬁdeTSGwasbasedontheclaimthat
it highly expressed in the normal healthy tissue.
As noted before, since the publication of Li et al paper, a large
body of literature has been published on the potential
involvement of Runx3 in a variety of cancers (Table S1 of
Supporting information). There is, however, an important
distinction between these previously published papers and the
data presented here: None of the previous reports has gone back
and carefully examined, using a variety of highly stringent
measures, whether Runx3 is actually expressed in the tissue in
which it was reported to be expressed. Instead, on the basis of Li
etal, themajority ofthis literatureassumed thatRunx3 isindeed
expressed in the normal GIT and acts as TS in the particular
epithelial cancer investigated.
The papers listed in Table S1 of Supporting information can
be placed into three distinct categories: (a) Papers, a signiﬁcant
number (145) of which took for granted that the published data
was correct and, because Li et al also described Runx3 DNA
methylation in cancer cells, proceeded to analyse the methyla-
tion status of the Runx3 gene in various cancers. However, as
was previously noted (Gal-Yam et al, 2008; Keshet et al, 2006;
Sproul et al, 2011), several hundred genes undergo methylation
in tumour cell genomes, most of which are not expressed in the
normal tissue of origin of these cancers. Therefore, a
demonstration of promoter methylation, on its own, does not
and cannot represent a proof or even a credible indication/
suggestion that the methylated gene is a TSG; (b) Papers that are
based on Li et al, but tested Runx3 expression in GIT Ep by IHC
using poorly characterized (or fully invalidated) Abs that in
several cases stained the cell cytoplasm instead of the nucleus.
Data in Fig 2A and Fig S1 of Supporting information provide
evidence showing that these Abs could not be construed as
being speciﬁc for Runx3 protein; (c) Papers that used either RT-
PCR or well characterized/validated Abs and failed, by either
method, to detect Runx3 expression in the Ep of the GIT.
In summary, using seven different stringent measures, we
herein provide compelling evidences that not only directly,
deﬁnitely and unequivocally rule out the possibility that Runx3
is expressed in WT GIT Ep, but also challenge the notion that
Runx3functions inthistissue asTSG. Additionally, thedataalso
callintoquestion thepotentialfunctionofRunx3asTSGinother
carcinomas.
MATERIALS AND METHODS
Generation of Runx3
LacZ/R, Runx3
P1-AFP/R and Runx3
P2-EGFP/R
KI mice
Generation of Runx3
LacZ/þ mice was previously described (Levanon
et al, 2002). Runx3
P1-AFP/þ mice were generated through use of the
Gene Bridges recombineering system (Gene Bridges, Heidelberg,
Germany) according to the manufacturers instructions. Briefly, a
7.7kb SalI fragment spanning 6 and 1.7kb regions upstream and
downstream, respectively, of the P1-ATG codon was cloned using BAC
145I18 (129S6/SvEvTac from RPCI-22 library, Genome Resource
Facility CHORI, Oakland, CA, USA), which spans the entire genomic
locus of Runx3. This 7.7kb SalI fragment was then recombineered by
insertion of an AFP-lox-PGK/neo-lox cassette at the initiator ATG of the
P1-transcription unit, while leaving the promoter and 50UTR intact.
The targeting fragment was cloned into a Diphtheria Toxin (DTA)
pKODT vector (Lexicon Genetics Inc. Texas, USA), which was linearized
and electroporated into ES cells (W4—derived from the 129S6/
SvEvTac from Taconic). Recombinant G418 resistant ES clones were
screened by Southern blotting using 50 and 30 probes. BamHI digest
revealed an 11.8kb fragment in WT, and 10.8 and 3.7kb fragments for
the targeted allele. Similarly, Runx3
P2-EGFP/þ mice were generated
using an EcoRV 8.1kb fragment spanning 3.2 and 4.9kb regions
upstream and downstream, respectively, of the P2-ATG codon, which
was cloned from the Runx3 BAC indicated above. This fragment was
modified by insertion of EGFP-lox-PGK/neo-lox cassette at the initiator
P2-ATG leaving the promoter and 50UTR intact. Selection of G418 ES
clones by Southern blotting employed a ScaI digest analysed with 50
and 30 probes. DNA of positive recombinant ES cells produced a
12.7kb fragment for WT, and 5.7 and 10.2kb fragments for the
targeted allele. The neo
F/F gene was subsequently removed by mating
germline transmitting Runx3
P1-AFP/þ and Runx3
P2-EGFP/þ KI mice with
transgenic Pgk-Cre mice. Both strains were then backcrossed onto ICR
mice. All experiments involving mice were approved by the Institu-
tional Animal Care and Use Committee (IACUC) of the Weizmann
Institute.
Generation of Runx3
Cre mice
Runx3
Cre mice were generated using recombineering as detailed
above. A 9kb SalI genomic fragment spanning 3.5 and 5.5kb regions
upstream and downstream, respectively, of Runx3 exon 4 was cloned
from the Runx3 BAC described above.This fragment was then modified
by recombineering using an EGFP-Cre cassette (pBS592, Addgene,
USA). This EGFP-Cre cassette, which consisted of EGFP-Cre-CSF-PolyA-
frt-Pgk/neo-frt was inserted in-frame into exon 4 (into the SmaI site)
creating Runx3-EGFP-Cre fused protein. We chose the SmaI site,
because it was utilized by Li et al (Li et al, 2002) to create the Kyoto-
Runx3
LacZ/LacZ mice, which gave rise to the strong LacZ stained GIT
reported in their paper Fig 1E (Li et al, 2002). The EGFP-Cre cassette
was selected because it combines the advantage of a GFP reporter and
more importantly, when used as EGFP-Cre fusion protein was shown
to be efficient in the excision of LoxP-flanked genomic fragments (Le
et al, 1999). The targeting fragment was electroporated into ES cells
(129X1/SvJ x 129S1) followed by selection of G418 ES clones using
Southern blotting of ScaI digest analysed with 50 and 30 probes. DNA of
positive recombinant ES cells produced an 11.1kb fragment for WT,
and 9.3 and 5.9kb fragments for the targeted allele.
The R26-stop
Flox-LacZ and R26-stop
Flox-tdTomato reporter
mouse strains
R26-stop
Flox-LacZ mice were obtained from the Jackson Laboratory
(strain name B6; 129S4-Gt(ROSA)26Sor
tm1Sor/J; stock No. 003309). Cre
expression in these mice results in the removal of a loxP-flanked DNA
segment (STOP cassette) that prevents expression of a lacZ gene.
When crossed with a cre expressing mouse strain, lacZ is expressed in
cells/tissues where cre is expressed. R26-stop
Flox-tdTomato
mice were also obtained from the Jackson Laboratory (strain name
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tm14(CAG-tdTomato)Hze/J; stock No. 007914). These
mice harbour a targeted mutation of the Gt(ROSA)26Sor locus with a
loxP-flanked STOP cassette preventing transcription driven by the
highly active CMV early enhancer/chicken b actin (CAG) promoter,
which then mediate the expression of cells/tissues specific red
fluorescent protein variant (tdTomato). These two mouse strains are
used here as Runx3-Cre reporters that express either LacZ or tdTomato
following Runx3-mediated expression of Cre-recombinase. Runx3
Cre
mice crossed onto the R26-stop
Flox-LacZ or R26-stop
Flox-tdTomato
reporter mouse strains, exhibited the characteristic Runx3
expression pattern with no expression in the GIT, whereas, when
crossed onto the general deleter strain Pgk-Cre, the R26-stop
Flox-LacZ
or R26-stop
Flox-tdTomato displayed ubiquitous blue staining or red
fluorescence, respectively, including strong staining in the GIT.
Analysis of Runx3 expression
Monitoring Runx3 expression via Runx3- LacZ or -GFP
X-Gal staining was performed as previously described (Levanon et al,
2001) using a standard procedure (Hames & Higgins, 1993). GFP
expression was viewed in whole mount embryos using a fluorescence
stereomicroscope (Leica MZ16F) equipped with GFP filter sets. AFP
and EGFP are variants of GFP recognized by the commercially
available anti-GFP Abs indicated below.
Immunohistochemistry (IHC) and immunofluorescence
IHC and immunofluorescence were conducted using paraffin sections
as previously described (Levanon et al, 2002). Runx3 was detected by
Vectastain kit (Vector Laboratories Burlingame, CA, USA) or, when
applicable, by the MOM kit for monoclonal Abs (Vector Laboratories
Burlingame).The following Abs were used: affinity purified rabbit anti-
Runx1 (1:100 dilution) produced in-house; polyclonal rabbit anti-
Runx3 ‘poly-G’ (1:1000; Levanon et al, 2002, 2001); monoclonal anti-
Runx3 Abs ‘Mono-G’ (1:200) raised in-house (in collaboration with
RCMDT, Russian Research Center, Moscow, Russia), against the Runx3
peptide—TPSTPSPRGSLSTTSHF; rabbit anti-RUNX3 ‘Poly-SA’ (1:1000)
produced by Sylvia Arber Biozentrum, Basel, Switzerland (Kramer et al,
2006); rabbit anti-Runx3 Abs ‘Pep-J’ (1:1000) raised against the
Runx3 peptide—AQATAGPGGRTRPEVRS by Joriene de Nooij in the
laboratory of Tom Jessell New York, NY, USA (Kramer et al, 2006); anti-
Runx3 Abs ‘GS’ raised by GeneScript, CRO (Piscataway, NJ, USA),
against the same peptide used by Joriene de Nooij; anti-AML2/Runx3
rabbit polyclonal (1:200) ACTIVE MOTIF (Carlsbad, CA USA) and
monoclonal anti-Runx3 Abs R3-1E10, R3-3F12 and R3-8C9 (1:200;
Fig S1A–C of Supporting information) raised in the laboratory of
Yoshiaki Ito against portions of Runx3 and subsequently characterized
(Ito et al, 2009); and goat polyclonal Abs against GFP (biotin) Ab-6658
(1:200) Abcam, Cambridge, UK.
Radioactive RNA in situ hybridizations
Radioactive RNA in situ hybridizations of Runx3 or Runx1 mRNAs were
performed as previously described (Brenner et al, 2004) using
35S-
labeled RNA probes. The Runx1 probe spanned 650bp of exon 6
between nucleotides 1114–1765 in GenBank accession No. D13802.
The Runx3 probe spanned 769bp of exon 6 between nucleotides
1035–1804 in GenBank accession #AF155880.
Flow cytometry
This was performed using single cell suspensions of embryonic
or adult GIT Ep derived from Runx3
P1-AFP/P2-EGFP, R26-LacZ/
Runx3
Cre or R26-tdTomato/Runx3
Cre reporter mouse strains. For
Runx3
P1-AFP/P2-EGFP, colon and cecum of adult WT and reporter mice
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The paper explained
PROBLEM:
Tumour suppressor genes (TSG) play an important role in
protecting normal tissues against cancer development. To
function as a tumour suppressor (TS), a gene must be
expressed in cells of the normal tissue, while loss of its
expression should give the cell a spur to growth that may
potentiallyleadto cancer.Almost10 yearsagoit wasreportedby
Li et al (2002) that Runx3 is an important TSG in gastrointestinal
tract (GIT) epithelium (Ep), based on their finding of its high
expression in GIT Ep of Runx3
LacZ/LacZ mouse embryos.
Subsequently, more than 280 papers have been published,
which based their research on the Li et al 2002 finding,
invoking the loss of Runx3 activity to explain the pathogenesis of
one or another type of human cancer. In these papers, the
correctness of the 2002 report that Runx3 is indeed a TSG has
always been assumed. Here, we re-examined in great detail and
using a variety of highly sensitive genetic, biochemical
andimmunohistochemicaltechniquesthemostcriticalquestion:
Is Runx3 indeed expressed in normal GIT Ep?
RESULTS:
Employing a variety of biochemical and genetic techniques,
including analysis of Runx3-GFP and R26LacZ/Runx3Cre or
R26tdTomato/Runx3Cre reporter strains, we readily detected
Runx3 in GIT-embedded leukocytes as well as in various other
known Runx3 expressing cells and organs. None of these
approaches, however,revealed detectable Runx3 levels in GIT Ep.
Moreover, the results of the R26LacZ/Runx3Cre and R26tdTo-
mato/Runx3Cre reporter analysis demonstrated that Runx3 was
not even transiently expressed at any time during epithelial
lineage development. Finally, a rigorous analysis of the original
Kyoto-Runx3
LacZ/LacZ mice used in the original Li et al study failed
to reproduce the reported LacZ staining in the GIT.
IMPACT:
ThelackofevidenceforRunx3expressioninnormalGITEpatany
stage of normal GIT development presents a serious challenge to
the published data and undermines the notion that Runx3 is a TS
involved in cancer pathogenesis.
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pieces and incubated twice for 20min at 37-C in Hanks balanced salt
solution (HBSS) containing 2mM EDTA, 1mM DTT and 5% FCS. The
two suspensions were combined, passed through a 100mm cell
strainer and washed twice in FACS buffer (PBS containing 5% FCS,
1mM EDTA and 0.05% Na azide). Preparations of GIT Ep contained
a substantial number of Runx3 expressing IELs, as documented in
Fig. 2. Cells were immunostained with anti EpCAM (BD Biosciences,
USA) in combination with anti-rat IgG Cy5 (Jackson ImmunoResearch)
or CD45-APC (BD Biosciences). The GITs (see Fig 5B, C and F) and
thymi of E16.5 R26-LacZ/Runx3
Cre or R26-tdTomato/Runx3
Cre
embryos were removed and single cell suspensions of thymocytes or
intestinal Ep were prepared. The cells obtained from R26-LacZ/
Runx3
Cre embryos were loaded with FDG (Molecular Probes; Eugene,
OR, USA) to detect LacZ-positive cells (North et al, 2004),
and thymocytes and epithelial cells from both R26-LacZ/Runx3
Cre
or R26-tdTomato/Runx3
Cre were immunostained with anti-CD45
(e-Bioscience, San-Diego, CA, USA) or anti-EpCAM (BD Biosciences) in
combination with anti-rat IgG Cy5 (Jackson ImmunoResearch). FACS
analysis was performed using BD LSRII (Becton Dickenson, USA) and
analysed by Flowjo software.
Reverse transcription quantitative real-time PCR (RT-qPCR)
RNA was prepared using RNeasy micro RNA preparation kits (Qiagen,
Hilden, BRD), according to manufacturer’s instructions. All samples
had OD260/280 ‡1.9 and OD 260/230 ‡1.0. Minimum two RNA preps
were done per cell type (i.e.E p C A M
Rand CD45
RNK). Reverse
transcription was carried out using SuperScript II (Invitrogen, Carlsbad,
CA, USA) and random hexamer primers, template concentration was in
the linear range of amplification. Endogenous control assays gave
statistically stable expression, and normalization factors were
calculated via geometric averaging of the two genes’ expression levels
using BestKeeper software (Pfaffl et al, 2004). Quantification was
calculated relative to the lowest-expressing sample as calibrator using
random pairwise allocation, and statistical significance using Taylor’s
series via REST 384 software (Pfaffl et al, 2002).
TaqMan assays of Runx3, HPRT1 and PBGD (Runx3-Mm00490666_
M1; HPRT1-Mm00446968_M1; PBGD-Mm00660262_G1) were pur-
chased from Applied Biosystems (ABI), and were confirmed 100%
efficient under in-house conditions.The HPRT1 and PBGD endogenous
control assays were chosen from different protein families with
differing biological functions, to ensure that normalization would be
stable and were confirmed to give signal within the range similar to
actual samples. Reactions were run with TaqMan Gene Expression
Master Mix (ABI #4369016) in a Roche LC480 realtime PCR
instrument under two-step absolute quantification with extended
denaturation times and Tm 61-C. Minimum three technical repeats of
each sample were run. All assays gave SD<0.35 for cycle thresholds
(Ct) values over all samples.
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